Gil Ben-Shlomo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gil Ben-Shlomo has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Rachel Anne Allbaugh
Department of Veterinary Clinical Sciences, College of Veterinary Medicine Iowa State University Ames Iowa USA
3 shared publications - Bret Alan Moore
Department of Clinical Sciences Cornell University Ithaca New York USA
2 shared publications Lionel Sebbag
Iowa State Univ, Coll Vet Med, Dept Vet Clin Sci, Ames, IA 50011 USA
2 shared publications- Norman Matthew Ellinwood
National MPS Society, Durham, NC 27709-4686, USA
2 shared publications Rachel A. Allbaugh
Iowa State Univ, Coll Vet Med, Dept Vet Clin Sci, Ames, IA 50011 USA
2 shared publicationsAdhithiya Charli
Department of Biomedical Sciences College of Veterinary Medicine Iowa State University Ames Iowa USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Ciência Rural
- Vol. 55 (8) , e20240397
Cone degeneration in two Shih Tzu dogs: clinical and genetic investigation
Two cases of cone degeneration in adult Shih Tzu canine patients are reported herein. Definitive diagnosis was made based on the ophthalmic examination finding, typical clinical signs, and characteristic electroretinography results that demonstrated normal rod function and absence of recordable cone function. Sanger sequencing of the entire coding sequence of the cyclic nucleotide gated channel β3 (CNGB3) gene did not reveal disease causing variants in these dogs. To the authors’ knowledge, this is the first report of clinical, electroretinographic and genetic investigation of cone degeneration in Shih Tzu.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Ciência Rural
- Vol. 55 (8) , e20240397
Open AccessCone degeneration in two Shih Tzu dogs: clinical and genetic investigation
Two cases of cone degeneration in adult Shih Tzu canine patients are reported herein. Definitive diagnosis was made based on the ophthalmic examination finding, typical clinical signs, and characteristic electroretinography results that demonstrated normal rod function and absence of recordable cone function. Sanger sequencing of the entire coding sequence of the cyclic nucleotide gated channel β3 (CNGB3) gene did not reveal disease causing variants in these dogs. To the authors’ knowledge, this is the first report of clinical, electroretinographic and genetic investigation of cone degeneration in Shih Tzu.
- 21 June 2022
- Published by Springer Nature
- p. 49-70
Ophthalmology of Afrotheria: Aardvarks, Hyraxes, Elephants, Manatees, and Relatives
- 21 June 2022
- Published by Springer Nature
- p. 49-70
Ophthalmology of Afrotheria: Aardvarks, Hyraxes, Elephants, Manatees, and Relatives
- Open Access
- 23 September 2021
- Published by Wiley in Veterinary Ophthalmology
- Vol. 24 (5) , 509-519
Interleukin‐6 and lactate dehydrogenase expression in a novel ex vivo rocking model of equine corneal epithelial wound healing
Purpose: To establish a physiologically relevant ex vivo model of equine corneal epithelial wound healing.Methods: Fourteen equine corneas were randomly assigned to one of two groups: wounded (n = 8) or unwounded (n = 6) controls. In the wounded group, the axial corneal epithelium was removed by applying a 6 mm filter paper disk soaked in 1N‐NaOH for 60 s. Corneas were subsequently cultured using an air‐liquid interface model. Evaluation of corneal healing was performed daily, and culture medium was collected. Corneas were randomly assigned to undergo processing via histopathology and RNAscope in situ hybridization for interleukin‐6 (IL‐6) and alpha‐smooth muscle actin (αSMA) expression at T24, T48, and T72 h after wounding. Media of the cultured corneas were evaluated for the presence of lactate dehydrogenase (LDH) by a colorimetric assay.Results: The ulcerated area of the wounded corneas decreased over time and all corneas healed within 72 h. Histologically, normal corneal architecture was observed including healthy epithelium (in areas other than the ulcerated ones), minimal stromal edema, intact endothelium, and Descemet's membrane. IL‐6 expression was increased in wounded corneas compared with unwounded controls. LDH expression was elevated for both wounded and unwounded corneas at T24 but decreased substantially and was not detected at T48 in media from wounded and unwounded corneas, respectively. No αSMA expression was detected from either wounded or unwounded corneas.Conclusions: The equine air‐liquid interface, ex vivo, corneal epithelial wound healing model is effective and physiologically relevant. This model can be used in future studies evaluating various corneal therapies.
- 23 September 2021
- Published by Wiley in Veterinary Ophthalmology
- Vol. 24 (5) , 509-519
Open AccessInterleukin‐6 and lactate dehydrogenase expression in a novel ex vivo rocking model of equine corneal epithelial wound healing
Purpose: To establish a physiologically relevant ex vivo model of equine corneal epithelial wound healing.Methods: Fourteen equine corneas were randomly assigned to one of two groups: wounded (n = 8) or unwounded (n = 6) controls. In the wounded group, the axial corneal epithelium was removed by applying a 6 mm filter paper disk soaked in 1N‐NaOH for 60 s. Corneas were subsequently cultured using an air‐liquid interface model. Evaluation of corneal healing was performed daily, and culture medium was collected. Corneas were randomly assigned to undergo processing via histopathology and RNAscope in situ hybridization for interleukin‐6 (IL‐6) and alpha‐smooth muscle actin (αSMA) expression at T24, T48, and T72 h after wounding. Media of the cultured corneas were evaluated for the presence of lactate dehydrogenase (LDH) by a colorimetric assay.Results: The ulcerated area of the wounded corneas decreased over time and all corneas healed within 72 h. Histologically, normal corneal architecture was observed including healthy epithelium (in areas other than the ulcerated ones), minimal stromal edema, intact endothelium, and Descemet's membrane. IL‐6 expression was increased in wounded corneas compared with unwounded controls. LDH expression was elevated for both wounded and unwounded corneas at T24 but decreased substantially and was not detected at T48 in media from wounded and unwounded corneas, respectively. No αSMA expression was detected from either wounded or unwounded corneas.Conclusions: The equine air‐liquid interface, ex vivo, corneal epithelial wound healing model is effective and physiologically relevant. This model can be used in future studies evaluating various corneal therapies.
- 1 December 2020
- Published by Elsevier in Experimental Eye Research
- Vol. 201, 108265
Electrolyte composition of tears in normal dogs and its comparison to serum and plasma
- 1 December 2020
- Published by Elsevier in Experimental Eye Research
- Vol. 201, 108265
Electrolyte composition of tears in normal dogs and its comparison to serum and plasma
- 15 October 2020
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 257 (8) , 833-839
Novel use of a combination of extracellular matrices for wound healing following resection of a large inferior eyelid mass in a miniature Hereford
CASE DESCRIPTION A 9-month-old miniature Hereford heifer was evaluated for a mass on the right inferior eyelid that had progressed in size over 3 months. CLINICAL FINDINGS Physical examination revealed a firm, ulcerated, pedunculated mass on the right inferior eyelid that extended from the medial quarter to beyond the lateral canthus of the eye. The base of the mass measured 7.4 X 6.7 cm, and the dorsal margin of the base of the mass was approximately 3 mm ventral to the inferior eyelid margin. Histologic evaluation of incisional biopsy specimens from the mass was consistent with fibrosarcoma. TREATMENT AND OUTCOME The mass was surgically resected with care taken to preserve the eyelid margin. The resulting 10 X 8.5-cm surgical wound was treated with adjunct CO2 laser therapy and closed by primary closure at its medial and central aspects and placement of a 4.6 X 2.6-cm lyophilized equine amnion multilayer graft and 2 sheets of 4-ply porcine small intestinal submucosa at its lateral aspect. The grafts were kept moist by alternating topical antimicrobial and artificial tear ointments for 3 weeks. The wound healed without complications, resulting in a functional and aesthetically pleasing outcome despite the development of moderate ectropion at the lateral aspect of the inferior eyelid. CLINICAL RELEVANCE Results suggested that a combination of extracellular matrix scaffolds may be an alternative to extensive skin flaps for management of large dermal wounds, particularly wounds resulting from blepharoplasty where preservation of an eyelid margin is desired.
- 15 October 2020
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 257 (8) , 833-839
Novel use of a combination of extracellular matrices for wound healing following resection of a large inferior eyelid mass in a miniature Hereford
CASE DESCRIPTION A 9-month-old miniature Hereford heifer was evaluated for a mass on the right inferior eyelid that had progressed in size over 3 months. CLINICAL FINDINGS Physical examination revealed a firm, ulcerated, pedunculated mass on the right inferior eyelid that extended from the medial quarter to beyond the lateral canthus of the eye. The base of the mass measured 7.4 X 6.7 cm, and the dorsal margin of the base of the mass was approximately 3 mm ventral to the inferior eyelid margin. Histologic evaluation of incisional biopsy specimens from the mass was consistent with fibrosarcoma. TREATMENT AND OUTCOME The mass was surgically resected with care taken to preserve the eyelid margin. The resulting 10 X 8.5-cm surgical wound was treated with adjunct CO2 laser therapy and closed by primary closure at its medial and central aspects and placement of a 4.6 X 2.6-cm lyophilized equine amnion multilayer graft and 2 sheets of 4-ply porcine small intestinal submucosa at its lateral aspect. The grafts were kept moist by alternating topical antimicrobial and artificial tear ointments for 3 weeks. The wound healed without complications, resulting in a functional and aesthetically pleasing outcome despite the development of moderate ectropion at the lateral aspect of the inferior eyelid. CLINICAL RELEVANCE Results suggested that a combination of extracellular matrix scaffolds may be an alternative to extensive skin flaps for management of large dermal wounds, particularly wounds resulting from blepharoplasty where preservation of an eyelid margin is desired.
- 10 March 2020
- Published by Wiley in Veterinary Ophthalmology
- Vol. 24 (S1) , 171-174
Estimation of intraocular pressure in normal canine eyes utilizing the newly introduced TonoVet Plus and TonoPen Avia, and their comparison to the established TonoVet
Purpose: To evaluate the IOP values obtained from normal canine eyes, by means of the TonoVet Plus (TVP) and TonoPen Avia (TPA), and compare them to an established tonometer, the TonoVet (TV).Methods: Tonometry was performed bilaterally in 50 healthy dogs, age 1‐11 years. The rebound tonometers (TV and TVP) were used first (in a random order), and then, one drop of tetracaine hydrochloride was applied to each eye, and approximately one minute later the IOP was estimated using the TPA. The mean ± standard deviation (SD) was calculated for each tonometer and a paired Student'sttest was used to compare the IOP values between tonometers. APvalue ≤ .05 was considered significant. The agreement between tonometers was assessed by a Bland‐Altman plot.Results: The mean ± SD (range) IOP values were 15.0 ± 3.2 mm Hg (7‐22), 19.2 ± 3.1 mm Hg (11‐25), and 12.8 ± 2.9 mm Hg (6‐19), for the TV, TVP, and TPA, respectively. The IOP values obtained by each tonometer were significantly different compared to the other two (P < .0001). There was a good agreement with fixed bias between all tonometers.Conclusions: The average IOP values of the TVP were significantly higher than those of the TV, which were significantly higher than those of the TPA, in normal canine eyes. Knowing the normal IOP values for these tonometers and the bias between them will help the clinician with the interpretation of IOP values obtained by these devices and compare between them.
- 10 March 2020
- Published by Wiley in Veterinary Ophthalmology
- Vol. 24 (S1) , 171-174
Estimation of intraocular pressure in normal canine eyes utilizing the newly introduced TonoVet Plus and TonoPen Avia, and their comparison to the established TonoVet
Purpose: To evaluate the IOP values obtained from normal canine eyes, by means of the TonoVet Plus (TVP) and TonoPen Avia (TPA), and compare them to an established tonometer, the TonoVet (TV).Methods: Tonometry was performed bilaterally in 50 healthy dogs, age 1‐11 years. The rebound tonometers (TV and TVP) were used first (in a random order), and then, one drop of tetracaine hydrochloride was applied to each eye, and approximately one minute later the IOP was estimated using the TPA. The mean ± standard deviation (SD) was calculated for each tonometer and a paired Student'sttest was used to compare the IOP values between tonometers. APvalue ≤ .05 was considered significant. The agreement between tonometers was assessed by a Bland‐Altman plot.Results: The mean ± SD (range) IOP values were 15.0 ± 3.2 mm Hg (7‐22), 19.2 ± 3.1 mm Hg (11‐25), and 12.8 ± 2.9 mm Hg (6‐19), for the TV, TVP, and TPA, respectively. The IOP values obtained by each tonometer were significantly different compared to the other two (P < .0001). There was a good agreement with fixed bias between all tonometers.Conclusions: The average IOP values of the TVP were significantly higher than those of the TV, which were significantly higher than those of the TPA, in normal canine eyes. Knowing the normal IOP values for these tonometers and the bias between them will help the clinician with the interpretation of IOP values obtained by these devices and compare between them.
- 22 July 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 28 (5) , 810-816
A Multifunctional Smart Soft Contact Lens Device Enabled by Nanopore Thin Film for Glaucoma Diagnostics and In Situ Drug Delivery
In this paper, we report a new power-free multifunctional soft contact lens device that can measure intraocular pressure (IOP), achieve extended drug delivery in situ, and detect glaucoma biomarkers, all within the same device. Experiments demonstrate that the contact lens sensor can detect Interleukin 12p70, one possible biomarker for glaucoma, in a concentration as low as 2 pg/ml in artificial tears. The sustained drug release of the contact lens device can last up to 30 days. In bfex vivo tests using cadaver pig eyes, the sensor detected IOP in a range of 10-50 mmHg with excellent repeatability. [2019-0067]
- 22 July 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 28 (5) , 810-816
A Multifunctional Smart Soft Contact Lens Device Enabled by Nanopore Thin Film for Glaucoma Diagnostics and In Situ Drug Delivery
In this paper, we report a new power-free multifunctional soft contact lens device that can measure intraocular pressure (IOP), achieve extended drug delivery in situ, and detect glaucoma biomarkers, all within the same device. Experiments demonstrate that the contact lens sensor can detect Interleukin 12p70, one possible biomarker for glaucoma, in a concentration as low as 2 pg/ml in artificial tears. The sustained drug release of the contact lens device can last up to 30 days. In bfex vivo tests using cadaver pig eyes, the sensor detected IOP in a range of 10-50 mmHg with excellent repeatability. [2019-0067]
- 15 August 2018
- Published by Wiley in Veterinary Ophthalmology
- Vol. 22 (4) , 407-414
MicroPulse™transscleral cyclophotocoagulation in the treatment of canine glaucoma: Preliminary results (12 dogs)
Objective: To describe the clinical application and effect of MicroPulse™ transscleral cyclophotocoagulation (MP‐TSCPC) in dogs with glaucoma.Animals studied: Twelve dogs with primary (n = 8) or secondary (n = 4) glaucoma, aged 2‐13 years (mean ±SD, 7.2 ± 3.8 years).Procedures: MP‐TSCPCwas performed under sedation or general anesthesia. Laser duty cycle was 31.3%, laser power varied from 2000‐2800mW, and each hemisphere was treated for 90‐180 seconds. The probe was applied to each quadrant in a “sweeping motion,” sparing the 3 and 9 o'clock positions.Results: The number ofMP‐TSCPCprocedures per eye varied from 1 to 3 (1.4 ± 0.7). Intraocular pressure (IOP) was controlled (<25 mm Hg) in 11/12 dogs (92%) within 1‐15 days post‐operatively. TheIOPcontrol at 1 month and the duration between repeated procedures were significantly greater in eyes treated with high energy laser (2800mW) compared to 2000‐2500mW. Long‐term follow‐up (315.3 ± 100.7 days) showed controlledIOPin 5/12 (42%) and vision retention in 4/8 (50%) dogs. In unsuccessful cases, loss ofIOPcontrol or vision loss occurred within 3‐245 days (109.1 ± 93.7 days) and 28‐261 days (114 ± 101.6 days), respectively, resulting in a salvage procedure in 6 dogs. Complications were as follows: corneal hypoesthesia (92%), anterior uveitis (67%), post‐operative ocular hypertension (50%), neurotrophic corneal ulcer (25%), keratoconjunctivitis sicca (8%), and rubeosis iridis (8%).Conclusions: MP‐TSCPCis a viable tool for managing canine glaucoma, although further studies are required to improve the long‐term effect and reduce the complication rate.
- 15 August 2018
- Published by Wiley in Veterinary Ophthalmology
- Vol. 22 (4) , 407-414
MicroPulse™transscleral cyclophotocoagulation in the treatment of canine glaucoma: Preliminary results (12 dogs)
Objective: To describe the clinical application and effect of MicroPulse™ transscleral cyclophotocoagulation (MP‐TSCPC) in dogs with glaucoma.Animals studied: Twelve dogs with primary (n = 8) or secondary (n = 4) glaucoma, aged 2‐13 years (mean ±SD, 7.2 ± 3.8 years).Procedures: MP‐TSCPCwas performed under sedation or general anesthesia. Laser duty cycle was 31.3%, laser power varied from 2000‐2800mW, and each hemisphere was treated for 90‐180 seconds. The probe was applied to each quadrant in a “sweeping motion,” sparing the 3 and 9 o'clock positions.Results: The number ofMP‐TSCPCprocedures per eye varied from 1 to 3 (1.4 ± 0.7). Intraocular pressure (IOP) was controlled (<25 mm Hg) in 11/12 dogs (92%) within 1‐15 days post‐operatively. TheIOPcontrol at 1 month and the duration between repeated procedures were significantly greater in eyes treated with high energy laser (2800mW) compared to 2000‐2500mW. Long‐term follow‐up (315.3 ± 100.7 days) showed controlledIOPin 5/12 (42%) and vision retention in 4/8 (50%) dogs. In unsuccessful cases, loss ofIOPcontrol or vision loss occurred within 3‐245 days (109.1 ± 93.7 days) and 28‐261 days (114 ± 101.6 days), respectively, resulting in a salvage procedure in 6 dogs. Complications were as follows: corneal hypoesthesia (92%), anterior uveitis (67%), post‐operative ocular hypertension (50%), neurotrophic corneal ulcer (25%), keratoconjunctivitis sicca (8%), and rubeosis iridis (8%).Conclusions: MP‐TSCPCis a viable tool for managing canine glaucoma, although further studies are required to improve the long‐term effect and reduce the complication rate.
- 24 May 2018
- Published by Wiley in Veterinary Ophthalmology
- Vol. 22 (3) , 222-228
Evaluation of microbial contamination of canine plasma eyedropper bottles following clinical use in canine patients
Objective: To investigate microbial contamination of canine plasma eye drops when used clinically and to compare the effect of two different eyedropper bottles on contamination rate.Methods: Forty‐six bottles containing plasma were randomly dispensed for use on 42 dogs with ulcerative keratitis. Of these, 23 were standard eyedropper bottles and 23 were Novelia®bottles designed to prevent contamination. After use for up to 2 weeks, samples for bacterial culture were obtained from a drop of plasma, the bottle tip, the plasma inside the bottle, and the corneal surface. Fungal culture was performed from a drop of plasma.Results: The overall microbial contamination rate was 17.4% (8/46 bottles); however, only one bottle had growth from the plasma inside the bottle. There was a lower contamination rate of Novelia®bottles (3/23 = 13.0%) compared to standard bottles (5/23 = 21.7%), but this difference was not statistically significant (P= .57). There were also no significant differences in contamination rate of bottles used greater than 7 days compared to less than or equal to 7 days, or in bottles used greater than 4 times daily compared to 4 times daily or less. Three corneal samples (6.5%) had bacterial growth, but none matched contamination from the bottles.Conclusions: Novelia®bottles may decrease contamination of plasma eye drops used clinically. However, while microbial contamination of plasma bottles was documented, no clinically relevant complications were observed. This study supports safe use of plasma eye drops for up to 2 weeks when refrigerated and dispensed from either Novelia®or standard eyedropper bottles.
- 24 May 2018
- Published by Wiley in Veterinary Ophthalmology
- Vol. 22 (3) , 222-228
Evaluation of microbial contamination of canine plasma eyedropper bottles following clinical use in canine patients
Objective: To investigate microbial contamination of canine plasma eye drops when used clinically and to compare the effect of two different eyedropper bottles on contamination rate.Methods: Forty‐six bottles containing plasma were randomly dispensed for use on 42 dogs with ulcerative keratitis. Of these, 23 were standard eyedropper bottles and 23 were Novelia®bottles designed to prevent contamination. After use for up to 2 weeks, samples for bacterial culture were obtained from a drop of plasma, the bottle tip, the plasma inside the bottle, and the corneal surface. Fungal culture was performed from a drop of plasma.Results: The overall microbial contamination rate was 17.4% (8/46 bottles); however, only one bottle had growth from the plasma inside the bottle. There was a lower contamination rate of Novelia®bottles (3/23 = 13.0%) compared to standard bottles (5/23 = 21.7%), but this difference was not statistically significant (P= .57). There were also no significant differences in contamination rate of bottles used greater than 7 days compared to less than or equal to 7 days, or in bottles used greater than 4 times daily compared to 4 times daily or less. Three corneal samples (6.5%) had bacterial growth, but none matched contamination from the bottles.Conclusions: Novelia®bottles may decrease contamination of plasma eye drops used clinically. However, while microbial contamination of plasma bottles was documented, no clinically relevant complications were observed. This study supports safe use of plasma eye drops for up to 2 weeks when refrigerated and dispensed from either Novelia®or standard eyedropper bottles.